PRINCIPAL FINANCIAL GROUP INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1126328
DES MOINES, IA
Position in VRTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$190,459,579
+$2,269,843 QoQ
Shares Held
426,523
+2.8% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. VRTX ranks #2 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $190,459,579 | 426,523 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $188,189,736 | 415,100 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $159,201,659 | 406,500 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $182,445,185 | 409,805 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $200,895,347 | 414,371 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $159,683,436 | 396,532 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $190,849,763 | 410,359 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $182,196,151 | 388,710 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $151,794,897 | 363,137 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $150,031,735 | 368,728 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $114,310,135 | 328,723 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $116,462,150 | 330,943 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $105,103,256 | 333,587 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $95,621,988 | 331,124 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $103,121,986 | 356,158 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $89,165,963 | 316,427 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $78,509,431 | 300,837 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $67,266,114 | 306,312 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $58,053,143 | 320,046 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $63,591,681 | 315,388 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $82,394,977 | 348,629 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $99,966,002 | 367,360 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $113,708,910 | 391,681 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $87,719,077 | 368,645 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||